scorecardresearch
Business Today
Subscribe
Visual Stories Immersives UPSTART India BTShorts Weather BT Bazaar
BT Golf BT Golf BT-TR GCC Listing
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • zero mile samvad iim nagpur
News
Markets
Stocks
Aurobindo Pharma Ltd

Feedback
Aurobindo Pharma Ltd

Aurobindo Pharma Ltd (AUROPHARMA) Share Price

  • Sector: Pharmaceuticals (Mid Cap)
  • Volume: 1,612,818
Apr 01, 2024 12:56 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹1,109.10
₹20.35 (2.16%)
₹1106.55 Low
Today’s Performance
₹1131.55 High
₹504.65 Low
52 Week’s Performance
₹1177.1 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day 2.16%
  • 1 Week 5.88%
  • 1 Month 5.85%
  • 3 Months -0.09%
  • 6 Months 24.63%
  • 1 Year 112.88%
  • 3 Years 7.75%
  • 5 Years 7.19%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 1.00
  • Beta 0.62
  • 52-Week Low (₹) 504.65
  • 52-Week High (₹) 1,177.10
  • Price-to-Book (X)* 2.26
  • Dividend Yield (%) 0.69
  • Price-to-Earnings (P/E) (X)* 22.71
  • Earnings Per Share (₹) 47.97
  • Sector Price Earning (X)* 36.52
  • Market Cap (₹ Cr.)* 63,794.07
  • * Vaues as of last close price

COMPETITORS

BT TV

India's Furious Pushback Against US And Germany Over Kejriwal Remarks 4:08 India's Furious Pushback Against US And Germany Over Kejriwal Remarks
Driving Forces Behind India’s Real Estate Surge 1:33 Driving Forces Behind India’s Real Estate Surge
India Sotheby's Amit Goyal: Housing Prices To Rise 8-10% Annually 2:21 India Sotheby's Amit Goyal: Housing Prices To Rise 8-10% Annually
Dy CM D K Shivakumar's Brother D K Suresh Battles It Out With C N Manjunath At Bengaluru Rural 3:40 Dy CM D K Shivakumar's Brother D K Suresh Battles It Out With C N Manjunath At Bengaluru Rural
Talking Tech & Innovation With Tata Motors’ Sven Patuschka 22:52 Talking Tech & Innovation With Tata Motors’ Sven Patuschka
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

Jan 25, 2024 Sell
AUROPHARMA ,BNP PARIBAS ARBITRAGE
  • Qty 150001
  • Average Price ₹1,160.10
Jan 25, 2024 PURCHASE
AUROPHARMA ,MARSHALL WACE INVESTMENT STRATEGIES - SYSTEMATIC ALPHA PLUS FUND
  • Qty 15950
  • Average Price ₹1,160.10
Jan 25, 2024 PURCHASE
AUROPHARMA ,MARSHALL WACE INVESTMENT STRATEGIESGTOPS FUND
  • Qty 27571
  • Average Price ₹1,160.10
Jan 25, 2024 PURCHASE
AUROPHARMA ,SOCIETE GENERALE
  • Qty 1484323
  • Average Price ₹1,160.10
Jan 25, 2024 PURCHASE
AUROPHARMA ,MARSHALL WACE INVESTMENT STRATEGIES - EUREKA FUND
  • Qty 106480
  • Average Price ₹1,160.10
Jan 25, 2024 Sell
AUROPHARMA ,BNP PARIBAS ARBITRAGE
  • Qty 1484323
  • Average Price ₹1,160.10
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Oct 07, 2016 Sell
Aurobindo Pharma Ltd. ,SUNEELA RANI PENAKA
  • Qty 8660510
  • Average Price ₹849.30
May 30, 2014 Sell
Aurobindo Pharma Ltd. ,M/S MORGAN STANLEY ASIA SINGAPORE PTE
  • Qty 1732500
  • Average Price ₹669.92
May 30, 2014 PURCHASE
Aurobindo Pharma Ltd. ,ABU DHABI INVESTMENT AUTHORUTY - GULAB
  • Qty 1475687
  • Average Price ₹670.51
Sep 19, 2014 PURCHASE
Aurobindo Pharma Ltd. ,THE VANGUARD GROUP INC A/C VANGUARD EMERG. MKTS STOCK INDE
  • Qty 2360231
  • Average Price ₹875.94
Aug 29, 2013 Sell
Aurobindo Pharma Ltd. ,MACQUARIE BANK LIMITED
  • Qty 1940000
  • Average Price ₹180.97
Oct 07, 2016 Sell
Aurobindo Pharma Ltd. ,SUNEELA RANI PENAKA
  • Qty 8660510
  • Average Price ₹849.30
May 30, 2014 Sell
Aurobindo Pharma Ltd. ,M/S MORGAN STANLEY ASIA SINGAPORE PTE
  • Qty 1732500
  • Average Price ₹669.92
May 30, 2014 PURCHASE
Aurobindo Pharma Ltd. ,ABU DHABI INVESTMENT AUTHORUTY - GULAB
  • Qty 1475687
  • Average Price ₹670.51
Sep 19, 2014 PURCHASE
Aurobindo Pharma Ltd. ,THE VANGUARD GROUP INC A/C VANGUARD EMERG. MKTS STOCK INDE
  • Qty 2360231
  • Average Price ₹875.94
Aug 29, 2013 Sell
Aurobindo Pharma Ltd. ,MACQUARIE BANK LIMITED
  • Qty 1940000
  • Average Price ₹180.97
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Aurobindo Pharma Ltd share price previously?
Aurobindo Pharma Ltd share price was up by 2.16% from the previous closing price of ₹1,088.75.
Who are peers of Aurobindo Pharma Ltd?
The peers of Aurobindo Pharma Ltd are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Zydus Lifesciences Ltd, Mankind Pharma Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Lupin Ltd, Alkem Laboratories Ltd, Glaxosmithkline Pharmaceuticals Ltd, Biocon Ltd, Ipca Laboratories Ltd, Gland Pharma Ltd, Syngene International Ltd, Ajanta Pharma Ltd.
Who is/are the promoter/promoters of Aurobindo Pharma Ltd?
The promotor/promotors of Aurobindo Pharma Ltd are K Ragunathan, Kambam Nityananda Reddy, M Sivakumaran, M Madan Mohan Reddy, P V Ramprasad Reddy, Savita Mahajan, Girish Paman Vanvari, P Sarath Chandra Reddy, Santanu Mukherjee, Deepali Pant Joshi.
What has been 52-week high of Aurobindo Pharma Ltd stocks?
The highest price of Aurobindo Pharma Ltd stock is ₹1,177.10 in the last 52-week.
What is the share price of Aurobindo Pharma Ltd (AUROPHARMA) today on NSE?
As on Apr 01, 2024, Aurobindo Pharma Ltd (AUROPHARMA)’s share price on NSE is Rs 1109.1
What is the market cap of Aurobindo Pharma Ltd (AUROPHARMA?)
The current market capitalisation of Aurobindo Pharma Ltd (AUROPHARMA) is 63,794.07 crores
What is Aurobindo Pharma Ltd Share symbol?
The symbol of Aurobindo Pharma Ltd is AUROPHARMA.
What is the PE ratio of Aurobindo Pharma Ltd (AUROPHARMA)?
The current PE ratio of Aurobindo Pharma Ltd (AUROPHARMA) is 22.71.
What is the PB ratio of Aurobindo Pharma Ltd (AUROPHARMA)?
The current PB ratio of Aurobindo Pharma Ltd (AUROPHARMA) is 2.26.
Today’s High & Low share prices of Aurobindo Pharma Ltd (AUROPHARMA) on NSE?
Today, the share price of Aurobindo Pharma Ltd (AUROPHARMA) on NSE touched a high of Rs 1131.55 and a low of Rs 1106.55
What price did Aurobindo Pharma Ltd (AUROPHARMA) shares open on the NSE today?
On NSE, the share price of Aurobindo Pharma Ltd (AUROPHARMA) opened at Rs 1113
What is the 52-week high of Aurobindo Pharma Ltd (AUROPHARMA)?
The 52-week high price of Aurobindo Pharma Ltd (AUROPHARMA) is Rs 1177.1
What is the 52-week low of Aurobindo Pharma Ltd (AUROPHARMA) ?
The 52-week low price of Aurobindo Pharma Ltd (AUROPHARMA) is Rs 504.65

ABOUT AUROBINDO PHARMA

Aurobindo Pharma Ltd, incorporated in the year 1986, has its registered office in Plot No 2 Maitrivihar, Behind Maithri Vanam Ameerpet, Hyderabad, Telangana, 500038, 91-40-23736370, 91-40-23747340. The main industry in which Aurobindo Pharma Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Aurobindo Pharma Ltd is/are Deloitte Haskins & Sells. In the main management, K Ragunathan is chairman and is the company secretary for Aurobindo Pharma Ltd.

  • KR K Ragunathan Chairman & Independent Directo
  • KNR Kambam Nityananda Reddy Executive Director
  • MS M Sivakumaran Executive Director
  • MMMR M Madan Mohan Reddy Executive Director
  • PVRR P V Ramprasad Reddy Non Executive Director
  • SM Savita Mahajan Independent Non Exe. Director
  • GPV Girish Paman Vanvari Independent Non Exe. Director
  • PSCR P Sarath Chandra Reddy Independent Non Exe. Director
  • SM Santanu Mukherjee Independent Director
  • DPJ Deepali Pant Joshi Additional Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement